openPR Logo
Press release

New Opportunities to Fuel the Expansion of Cardiac POC Testing Devices Market to US$ 4.1 Bn By 2025

03-29-2018 12:53 PM CET | Health & Medicine

Press release from: Medical Devices

New Opportunities to Fuel the Expansion of Cardiac POC Testing

SEATTLE, WA, 2018-Mar-29 — /openPR/ —

The market for cardiac POC testing devices is gaining significant traction due to rising prevalence of cardiac disorders. According to World Health Organizations (WHO), 2011, around 8 million people suffered from coronary and peripheral heart diseases, which recorded the major cause of all the deaths, accounting for around 44% of total deaths in the U.S. Technological innovations and developments of cardiac POC testing devices are contributing to the market growth. For instance, the FDA approval of Firmware software in August 2017, launched by Abbott Laboratories is embedded in the hardware of a cardiac testing device. With this device, the cardiac rhythm can be easily monitored as well as control for the people at high-risk. However, lack of operating knowledge and economic instability in emerging economies are the factors restraining the market growth.

To understand Research Methodology, please click: https://www.coherentmarketinsights.com/insight/request-sample/192

Cardiac POC testing is a test performed for the diagnosis of heart disorders. POC or Point-of-care testing, also referred to as bedside test, is a diagnostic test at the point or position of care at the same place and time of patient care. Cardiac POC testing is a simple blood test that includes cholesterol and coagulation testing. Coagulation testing helps physicians examine the risk of developing thrombosis, clotting and bleeding inside blood vessels in the body, including the heart. Cardiac POC tests include Troponin, Creatine Kinase MB Isoenzyme s, and Brain Natriuretic Peptide (BNP) analysis, which are mainly employed to identify cardiovascular ailments such as, heart failure, myocardial infarction, and coronary syndromes. Cardiac POC testing device help to detect enzymes that are released at some point in heart failure and in vital cardiac conditions such as lactate dehydrogenase isoenzymes, brain Natriuretic Peptide s, kinase, and synthesizing Troponin.

Increasing purchasing power and high prevalence are factors fueling growth of the cardiac POC testing device market

Rise in the geriatric population, associated with high susceptibility to chronic diseases related to cardiac disorders, and economical diagnosis of chronic diseases in rural areas are expected to boost growth of the global market. The cardiac POC testing devices market in Asia Pacific is expected to experience rapid growth over the forecast period, due to growing population and increasing purchasing power of patients. The key players are executing new strategies such as mergers and acquisitions, product launch, and medical symposium for better exposure of their products and to increase market share. The new product launch, collaborations between manufacturers, hospitals, and academic institutions are expected to establish a positive impact on the market growth. For instance, the global healthcare company, Abbott Laboratories has launched a software firmware in July 2017, which is embedded in the cardiac testing device. Moreover, Abbott Laboratories has acquired cardiac device maker, St. Jude Medical, at the stock deal of US$ 25 billion. The collaboration aims to produce a significant amount of new medical devices centered on patients suffering from cardiovascular disorders.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/192

Increasing prevalence of cardiac disorders significantly drives growth of the cardiac POC testing devices market

According to the FH Foundation, a patient-centered organization devoted to research and education of Familial Hypercholesterolemia (FH), 2015, 1 in 200-500 people suffered from familial hypercholesterolemia worldwide. With increasing population, this number expected to increase in the future, thereby leading to growth in demand for testing cholesterol levels in individuals. This in turn, is expected to propel the overall growth of the cardiac POC testing devices market. According to the World Health Organization 2013, around 33.5 million of the global population was estimated to have suffered from coronary artery disease, a major condition leading to heart attack. The growing prevalence of cardiovascular ailments is expected to increase the demand for cardiac POC testing devices, in turn, driving growth of the market. Additionally, The Patient Protection and Affordable Care Act, called Obamacare, was implemented under the Hospital Readmissions Reduction Program (HRRP), by the U.S. government in 2015 to impose penalties on hospitals. According to the penalty, the government had reduced up to 1-2% in the Medicare payment per patient, for hospital readmission within 30 days. This reduces the cost for diagnosis, in turn, accelerating growth of the cardiac POC testing devices market.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Opportunities to Fuel the Expansion of Cardiac POC Testing Devices Market to US$ 4.1 Bn By 2025 here

News-ID: 997779 • Views:

More Releases from Medical Devices

Medical Aesthetics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Medical Aesthetics Market - Global Industry Insights, Trends, Outlook, and Oppor …
Medical aesthetics is an area of medicine, dealing with aesthetics, well-being, external appearance, visible skin changes, and image of the patient. Medical aesthetics involve high-technology skin care procedures that represents the fusion of beauty and healthcare services. Procedures for these involves use of advanced technologies to enhance aesthetics of the person. Demand for anti-aging products and procedures is increasing significantly, owing to increasing focus of patients to look young and
Ophthalmic Ultrasound Imaging Systems Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Ophthalmic Ultrasound Imaging Systems Market - Global Industry Insights, Trends, …
Ophthalmic ultrasound imaging system is non-invasive visualization technique, which is more convenient and relatively inexpensive as compared to other techniques such as optical coherence tomography (OCT), magnetic resonance imaging (MRI), and scanning Scheimpflug. Ophthalmic ultrasound imaging systems allow imaging of anatomy and pathology involving the anterior and posterior segment of the eye. This system provides diagnostic information in conditions such as glaucoma, trauma, cysts, and neoplasms. It also allows measurement
Eye Anatomical Model Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
Eye Anatomical Model Market - Global Industry Insights, Trends, Outlook, and Opp …
Eye anatomical model refers to the type of reference models that are used to study the internal and external structures of the eye. These models are majorly used by educational institutes and optometry departments by professors to explain the internal and external anatomy of the eye in detail. These are also found to be used by professional healthcare providers such as ophthalmologists as well as opticians to educate their patients
Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of

All 5 Releases


More Releases for POC

Primary Catalyst Driving POC Medical Imaging Market Evolution in 2025: Chronic D …
What market dynamics are playing a key role in accelerating the growth of the poc medical imaging market? The escalating occurrence of long-term diseases is predicted to boost the expansion of the point-of-care medical imaging market in the future. The chronic disease prevalence pertains to the fraction or the count of people in a community affected by enduring health ailments at any given moment. This transition originates from lifestyle options, inherited
Transforming the Point-of-Care (POC) Coagulation Testing Market in 2025: Cardiov …
"What Is the Expected Size and Growth Rate of the Point-of-Care (POC) Coagulation Testing Market? The point-of-care (POC) coagulation testing market has grown significantly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025, at a CAGR of 5.8%. The growth is driven by increasing patient demand, the growing trend of point-of-care testing, high reliability in coagulation status testing, automation, integration with electronic health records
POC Diagnostic Testing Devices | 1drop
1drop Inc.'s POC diagnostic testing devices are essential tools in modern healthcare, designed to deliver quick and accurate results for various health conditions at the point of care. These devices make diagnostics more accessible and timelier, enhancing healthcare delivery and patient outcomes. Point-of-Care Molecular Diagnostic Platform 1drop offers a comprehensive POC molecular diagnostic platform that consists of three main components: • Reagent: Specialized reagents formulated for specific tests, including molecular diagnostics. • Device: The 1POT™ Duo
POC Diagnostics Market Size 2024 to 2031.
Market Overview and Report Coverage POC, or Point of Care, Diagnostics refer to medical tests that are performed outside of a traditional laboratory setting, allowing for quicker results and immediate treatment decisions. The POC Diagnostics Market encompasses a wide range of diagnostic tests including blood glucose monitoring, pregnancy tests, infectious disease testing, and more. The future outlook of the POC Diagnostics Market is optimistic, with the market expected to grow
Point of Care (POC) Coagulation Testing Devices Market - Transforming Coagulatio …
Newark, New Castle, USA: The "Point of Care (POC) Coagulation Testing Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Point of Care (POC) Coagulation Testing Devices
POC Cardiovascular Diagnostic Market 2022 | Detailed Report
According to Market Study Report, POC Cardiovascular Diagnostic Market provides a comprehensive analysis of the POC Cardiovascular Diagnostic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5467652 The report provides a comprehensive analysis of company profiles listed below: - Abbott - Biomerieux - Danaher - F.